Ebola virus disease (EVD), also known as Ebola hemorrhagic fever or Ebola, is caused by
the Ebola virus (EBOV). EBOV is a linear, nonsegmented, single negative-stranded RNA …

There is an increasing frequency of reports regarding the persistence of the Ebola virus
(EBOV) in Ebola virus disease (EVD) survivors. During the 2014–2016 West African EVD …

Neutralizing antibody function provides a foundation for the efficacy of vaccines and
therapies,–. Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection assay …

Viral pandemics often take the world by storm, urging the medical community to prioritize the
most evident systemic manifestations, often causing ocular manifestations to go unnoticed …

Emerging infectious diseases (EIDs) are an increasing threat to public health on a global
scale. In recent times, the most prominent outbreaks have constituted RNA viruses …

Recently recognized forms of uveitis include intraocular inflammations that occur during or
following one of several emerging infectious diseases: chikungunya fever, dengue, Zika …

Recent disease outbreaks have demonstrated the severe health, economic and political
crises that epidemics can trigger. The rate of emergence of infectious diseases is …

Despite increasing evidence that uveitis is common and consequential in survivors of Ebola
virus disease (EVD), the host-pathogen determinants of the clinical phenotype are …

Ebola virus (EBOV) causes severe hemorrhagic fever in humans with high mortality. In
Ebola virus disease (EVD) survivors, EBOV persistence in the eyes may break through the …

Thoroughly understanding the ophthalmic findings and transmission risk associated with
COVID-19 is paramount during this pandemic, providing additional measures of safety while …